Donaldson CO INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Donaldson Company, Inc. reported a decrease in net earnings and diluted EPS for fiscal year 2025, primarily due to a significant impairment charge in its Life Sciences segment.
NYSE
Donaldson Company, Inc.'s 10-K filing reveals a year of solid growth, driven by strategic initiatives and strong performance across its Mobile, Industrial, and Life Sciences segments.